Indian manufacturers exporting to the US
Manufacturers preparing FDA 510(k) documentation, US Agent coordination, and registration planning.
- 510(k)
- US Agent
- Export
US FDA · 510(k)
US FDA 510(k) Consultant for Medical Device Market Access
Prepare FDA 510(k) premarket notification documentation with predicate strategy, substantial equivalence support, eSTAR readiness, and QMS alignment. NQSC can also help map India and EU dossiers where relevant.
- 25+Years Experience
- 500+Companies
- FDA 510(k) Support
- Predicate · eSTAR
510(k) pathway
- 1Confirm product code and classification
- 2Define predicate and substantial equivalence strategy
- 3Prepare 510(k) content and eSTAR structure
- 4Plan CDRH Portal submission readiness
510(k)PredicateeSTARSEProduct code
Which FDA pathway applies?
- Class I or II (510(k) required)Premarket notification · SE to predicate
- 510(k)-exempt deviceRegistration · listing · US Agent
- Change to own cleared deviceSpecial 510(k) where applicable
- Class III devicePMA pathway (not standard 510(k))
- No suitable predicateDe Novo evaluation may apply
Who needs this
Who needs US FDA 510(k) support
NQSC supports Indian exporters, first-time US filers, multi-market OEMs, IVD teams, exempt-device companies, and post-clearance change planning.
First-time US filers
Teams new to FDA product codes, establishment registration, device listing, and 510(k) content requirements.
- Product code
- Listing
- eSTAR
Multi-market OEMs
OEMs aligning FDA 510(k) documentation with India CDSCO and EU technical file records.
- FDA
- EU
- India
IVD manufacturers
IVD teams reviewing FDA classification and whether 510(k), De Novo, or other routes may apply.
- IVD
- Classification
- Performance
510(k)-exempt device companies
Companies with exempt Class I or II devices who still need registration, listing, and QMS readiness.
- Exempt
- Registration
- Listing
Post-clearance change teams
License holders planning design changes, Special 510(k) submissions, or FDA additional information responses.
- Special 510(k)
- Changes
- AI response
Compare routes
510(k) premarket notification vs 510(k)-exempt pathway
Understand whether your device requires a 510(k) submission or may be exempt before planning registration, listing, and documentation.
510(k) Premarket Notification
Best for: devices that require FDA review of substantial equivalence before US marketing.
- Demonstrates substantial equivalence to a legally marketed predicate device
- Generally submitted electronically using eSTAR through the CDRH Portal
- FDA issues a clearance letter before commercial distribution when required
Relevant forms
- 510(k)
- Predicate
- eSTAR
- SE
510(k)-Exempt Device
Best for: Class I or Class II devices that meet applicable exemption limitations.
- May not require a 510(k) if exempt and within 21 CFR xxx.9 limitations
- Establishment registration and device listing are still commonly required
- Foreign manufacturers typically need a US Agent for FDA communication
Relevant forms
- Exempt
- Registration
- Listing
- US Agent
Documentation
Documentation typically reviewed for 510(k) readiness
Grouped for gap review before eSTAR submission or exemption and registration planning.
Classification & Predicate
- FDA product code and regulation number
- Device class and pathway confirmation
- Predicate device identification
- Substantial equivalence comparison outline
Device Description & SE
- Device description and intended use
- Technological characteristics summary
- Differences discussion and SE rationale
- 510(k) summary per 21 CFR 807.92
Performance & Testing
- Bench and verification or validation data
- Biocompatibility and sterilization evidence
- EMC and software validation where applicable
- Test reports with protocols and acceptance criteria
Labeling & IFU
- US draft labeling and indications
- Contraindications and warnings
- IFU and packaging artwork for US market
- Predicate labeling comparison where applicable
QMS & Administrative
- ISO 13485 or QSR 21 CFR 820 readiness summary
- US Agent designation for foreign establishments
- Establishment registration and device listing planning
- Declaration of Conformity planning where applicable
eSTAR & Submission Readiness
- eSTAR structure and attachment planning
- User fee and submission timing coordination
- Pre-Submission or Q-Submission materials if used
- Deficiency and additional information response planning
Note: Final document scope is confirmed after reviewing product code, classification, exemption status, and selected FDA pathway.
Process
From classification to 510(k) clearance readiness
A structured process for product code confirmation, pathway selection, substantial equivalence documentation, eSTAR preparation, and FDA review support.
Classification and product code
Confirm FDA classification, product code, and whether the device may be 510(k)-exempt within applicable limitations.
Exemption and pathway selection
Select Traditional, Special, or Abbreviated 510(k) where applicable, or plan registration and listing if exempt.
Predicate and SE documentation
Identify predicate devices and prepare substantial equivalence comparison tables and supporting discussion.
Evidence and labeling assembly
Compile performance, sterilization, software, biocompatibility, and US labeling evidence for the submission.
eSTAR and CDRH Portal readiness
Complete eSTAR content, user fee planning, and electronic submission readiness through the CDRH Portal.
Review support and post-clearance
Support FDA review correspondence and post-clearance registration, listing, and change planning.
How NQSC helps
Support across predicate strategy, 510(k) content, and eSTAR filing
NQSC supports classification review, predicate and SE documentation, performance and labeling alignment, eSTAR readiness, FDA correspondence, and post-clearance planning.
Classification and product code
Confirm FDA product code, device class, and whether 510(k), exemption, or another pathway may apply.
Predicate and SE strategy
Identify predicate devices and structure substantial equivalence comparisons per 21 CFR 807.87.
510(k) content and eSTAR
Prepare device description, performance evidence, labeling, and eSTAR-ready submission structure.
Testing and labeling alignment
Align bench, biocompatibility, sterilization, software, and US labeling with FDA expectations.
FDA review support
Support additional information requests, deficiency responses, and correspondence during FDA review.
Post-clearance changes
Plan design changes, Special 510(k) where applicable, and ongoing registration and listing updates.
Avoid delays
Avoidable issues that delay 510(k) readiness
Issues NQSC often sees during FDA 510(k) documentation and submission preparation reviews.
Weak predicate argument
Insufficient comparison of intended use, technological characteristics, and performance data against the selected predicate device.
Test report gaps
Standards cited without full protocols, acceptance criteria, or traceability to substantial equivalence claims.
Label and IFU US mismatch
US labeling, indications, or IFU content not aligned with the 510(k) submission set or predicate comparison.
510(k)-exempt misread
Assuming exemption from premarket notification removes establishment registration, device listing, or US Agent obligations.
Outdated submission format
Planning around legacy eCopy workflows instead of eSTAR and CDRH Portal electronic submission requirements.
Wrong 510(k) program selected
Special or Abbreviated 510(k) chosen when eligibility criteria for the device change or predicate are not met.
Client trust
Client feedback on NQSC US FDA and regulatory support
Feedback from teams supported across FDA 510(k) documentation, CE marking, ISO certification, and compliance coordination.
ISO · CE · CDSCO
“Excellent support throughout certification activities, including ISO, CE marking and CDSCO submissions.”
CDSCO · Manufacturing
“Fast and accurate service.”
Regulatory Support
“We are fully satisfied with the services provided by NQSC.”
Selected clients supported by NQSC
FAQ
Questions before you apply
Short answers on 510(k), substantial equivalence, eSTAR, exemptions, and how NQSC supports your US pathway.
A 510(k) is a premarket submission to FDA demonstrating that a device is substantially equivalent to a legally marketed predicate device. FDA issues a clearance letter if the device is found substantially equivalent. Requirements are described in 21 CFR 807 Subpart E.
Substantial equivalence compares your device to a legally marketed predicate with the same intended use and appropriate technological characteristics. The comparison must show your device is as safe and effective as the predicate, with supporting data where differences exist.
Some Class I and Class II devices may be 510(k)-exempt with limitations under 21 CFR 862.9 through 892.9. Exemption status should be confirmed for your product code. Exemption from 510(k) does not remove establishment registration, device listing, or US Agent requirements for foreign firms.
NQSC supports documentation preparation and regulatory guidance. The submission is typically made by the sponsor or through arrangements with a US Agent or authorized submitter, depending on your setup.
eSTAR is FDA's electronic submission template for 510(k) submissions. Since October 1, 2023, 510(k) submissions are generally required to be submitted electronically using eSTAR through the CDRH Portal, unless a specific exemption or waiver applies.
Yes. NQSC can map existing EU technical documentation to FDA 510(k) structure and identify gaps in predicate strategy, labeling, performance evidence, and submission format.
Planning US FDA 510(k) clearance?
Share your product code, predicate approach, current documentation, and target submission timeline. NQSC will outline 510(k) readiness priorities.